Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Exchange Rate Effect of -$1000.0 for Q1 2026, down 102.63% year-over-year from $38000.0 in Q1 2025, and down 100.79% quarter-over-quarter from $127000.0 in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Exchange Rate Effect (2010 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Exchange Rate Effect history runs 17 years deep, the most recent figure standing at -$1000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 102.63% year-over-year to -$1000.0; the TTM figure through Mar 2026 stood at $673000.0 (up 209.25% YoY), while the FY2026 annual figure was $673000.0, up 209.25% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$1000.0, down from $127000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $410000.0 in Q2 2025, with the low at -$283000.0 in Q3 2024.
- The 5-year median for Exchange Rate Effect is $38000.0 (2025), against an average of $31470.6.
- The sharpest annual moves came in 2024 and 2025: Exchange Rate Effect slumped 528.89% in 2024, then jumped 258.91% in 2025.
- Sonoma Pharmaceuticals' Exchange Rate Effect stood at -$85000.0 in 2022, then surged by 165.88% to $56000.0 in 2023, then sank by 301.79% to -$113000.0 in 2024, then surged by 212.39% to $127000.0 in 2025, then plunged by 100.79% to -$1000.0 in 2026.
- Business Quant data shows SNOA's Exchange Rate Effect at -$1000.0 in Q1 2026, $127000.0 in Q4 2025, and $137000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 136,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136,000.00 |
| Jun 30, 2026 | 136,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Mar 31, 2026 | -1,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Sep 30, 2025 | 137,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 410,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Dec 31, 2024 | -113,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Sep 30, 2024 | -283,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Jun 30, 2024 | -258,000.00 |
| Mar 31, 2024 | -70,000.00 |
| Mar 31, 2024 | -70,000.00 |